Generated by AI
Ainos, Inc. is a dual-platform AI and biotechnology company focused on smelltech and immune therapeutics. Ainos, Inc. develops AI Nose, an electronic olfaction platform that uses AI and a smell language model to convert scent and volatile compounds into machine-readable Smell ID data. This technology is used in applications such as robotics, smart factories, semiconductor manufacturing, healthcare, senior care, and women’s health. The company also develops VELDONA, a low-dose oral interferon platform designed for human and animal health applications, including rare, autoimmune, and infectious disease programs. In addition, Ainos, Inc. works on point-of-care testing and related diagnostic products, positioning itself at the intersection of digital sensing, medical technology, and therapeutic development.
Website3050 Post Oak Boulevard
Houston, TX, 77056
United States
The latest articles about AIMD.
Detailed price information for Ainos Inc (AIMD-Q) from The Globe and Mail including charting and trades.
Summary of Nov 17's posts. Generated by AI.
Summary of Nov 16's posts. Generated by AI.
Summary of Nov 16's posts. Generated by AI.
Investors talking about AIMD also mention these. Each card shows that asset’s own numbers for the past 24 hours.
Valuation and earnings.